{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:41:04Z","timestamp":1761864064613,"version":"3.37.3"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,14]],"date-time":"2020-01-14T00:00:00Z","timestamp":1578960000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,1,14]],"date-time":"2020-01-14T00:00:00Z","timestamp":1578960000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Prim. Care Respir. Med."],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Patients treated for drug addiction have high asthma and COPD prevalence rates. The relative contributions of cigarette smoking, smoking intensity and possible smoking of other substances has not been described. We aimed to describe the prevalence and determinants of asthma and COPD in patients prescribed methadone as opioid substitution therapy (OST). In a cross-sectional study of an anonymised patient-level primary care dataset of UK inner-city general practices (<jats:italic>n<\/jats:italic>\u2009=\u200946), 321,395 patients aged \u226518 years were identified. A total of 676 (0.21%) had a record of a methadone ever issued in primary care. The association between respiratory disease and methadone prescribing was examined using logistic regression. Models were adjusted for potential effects of clustering by practice. A total of 97.3% of patients prescribed methadone were cigarette smokers, either current (81.2%) or ex-smokers (16.1%). The prevalences of asthma and COPD were higher in methadone patients (14.2% and 12.4%, respectively) compared to non-methadone patients (4.4% and 1.1%, respectively). Methadone was an independent determinant of asthma, adjusting for smoking status (OR 3.21; 95% CI: 2.52, 4.10) or for smoking intensity (3.08; 2.27, 4.19), and of COPD, adjusting for smoking status (6.00; 4.61, 7.80) or for smoking intensity (5.80; 4.12, 8.17). COPD and asthma prevalence were substantially higher in those prescribed methadone compared to those never prescribed methadone. Prescription of methadone was an independent predictor for both COPD and asthma, even after adjustment for smoking status and smoking intensity. Possible explanations include confounding by association with smoking of heroin or crack cocaine, both of which may have a causal association with COPD and asthma.<\/jats:p>","DOI":"10.1038\/s41533-019-0161-7","type":"journal-article","created":{"date-parts":[[2020,1,14]],"date-time":"2020-01-14T11:03:30Z","timestamp":1578999810000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["COPD and asthma in patients with opioid dependency: a cross-sectional study in primary care"],"prefix":"10.1038","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3741-6918","authenticated-orcid":false,"given":"S.","family":"Mehta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Parmar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4637-3454","authenticated-orcid":false,"given":"M.","family":"Kelleher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3538-2451","authenticated-orcid":false,"given":"C. J.","family":"Jolley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2047-8787","authenticated-orcid":false,"given":"P.","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4098-5399","authenticated-orcid":false,"given":"S.","family":"Durbaba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Ashworth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,14]]},"reference":[{"key":"161_CR1","unstructured":"Public Health England. Adult substance misuse statistics from the National Drug Treatment Monitoring System (NDTMS). https:\/\/www.nta.nhs.uk\/uploads\/adult-statistics-from-the-national-drug-treatment-monitoring-system-2015-2016[0].pdf (2016)."},{"key":"161_CR2","unstructured":"Public Health England. Adult substance misuse statistics from the National Drug Treatment Monitoring System (NDTMS). https:\/\/webarchive.nationalarchives.gov.uk\/20170807160803\/ http:\/\/www.nta.nhs.uk\/uploads\/young-peoples-statistics-from-the-national-drugtreatment-monitoring-system-2014-2015.pdf (London, 2015)."},{"key":"161_CR3","unstructured":"National Treatment Agency. Injecting drug use in England: a declining trend. https:\/\/www.bl.uk\/collection-items\/injecting-drug-use-in-england-a-declining-trend (London, 2010)."},{"key":"161_CR4","unstructured":"The United Kingdom Focal Point on Drugs. UK Focal Point on Drugs. https:\/\/webarchive.nationalarchives.gov.uk\/20170807160740\/ http:\/\/www.nta.nhs.uk\/focalpoint.aspx (London, 2015)."},{"key":"161_CR5","first-page":"CD003409","volume":"3","author":"L Amato","year":"2005","unstructured":"Amato, L., Davoli, M., Minozzi, S., Ali, R. & Ferri, M. Methadone at tapered doses for the management of opioid withdrawal. Cochrane Database Syst. Rev. 3, CD003409 (2005).","journal-title":"Cochrane Database Syst. Rev."},{"key":"161_CR6","first-page":"CD002209","volume":"3","author":"RP Mattick","year":"2009","unstructured":"Mattick, R. P., Breen, C., Kimber, J. & Davoli, M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst. Rev. 3, CD002209 (2009).","journal-title":"Cochrane Database Syst. Rev."},{"key":"161_CR7","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1016\/S0140-6736(08)60954-X","volume":"371","author":"RS Schottenfeld","year":"2008","unstructured":"Schottenfeld, R. S., Chawarski, M. C. & Mazlan, M. Maintenance treatment with buprenorphine and naltrexone for heroin dependence in Malaysia: a randomised, double-blind, placebo-controlled trial. Lancet 371, 2192\u20132200 (2008).","journal-title":"Lancet"},{"key":"161_CR8","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jsat.2016.05.001","volume":"67","author":"E Krebs","year":"2016","unstructured":"Krebs, E., Kerr, T., Wood, E. & Nosyk, B. Characterizing long-term health related quality of life trajectories of individuals with opioid use disorder. J. Subst. Abuse Treat. 67, 30\u201337 (2016).","journal-title":"J. Subst. Abuse Treat."},{"key":"161_CR9","doi-asserted-by":"crossref","first-page":"e499","DOI":"10.3399\/bjgp13X669220","volume":"63","author":"J Parmenter","year":"2013","unstructured":"Parmenter, J. et al. Predicting biopsychosocial outcomes for heroin users in primary care treatment: a prospective longitudinal cohort study. Br. J. Gen. Pract. 63, e499\u2013e505 (2013).","journal-title":"Br. J. Gen. Pract."},{"key":"161_CR10","doi-asserted-by":"crossref","unstructured":"Kimber, J. et al. Survival and cessation in injecting drug users: prospective observational study of outcomes and effect of opiate substitution treatment. BMJ 341, c3172 (2010).","DOI":"10.1136\/bmj.c3172"},{"key":"161_CR11","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.drugalcdep.2014.09.782","volume":"146","author":"M Pierce","year":"2015","unstructured":"Pierce, M., Bird, S. M., Hickman, M. & Millar, T. National record linkage study of mortality for a large cohort of opioid users ascertained by drug treatment or criminal justice sources in England, 2005\u20132009. Drug Alcohol Depend. 146, 17\u201323 (2015).","journal-title":"Drug Alcohol Depend."},{"key":"161_CR12","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.drugalcdep.2016.08.627","volume":"167","author":"L Gao","year":"2016","unstructured":"Gao, L. et al. Risk-factors for methadone-specific deaths in Scotland\u2019s methadone-prescription clients between 2009 and 2013. Drug Alcohol Depend. 167, 214\u2013223 (2016).","journal-title":"Drug Alcohol Depend."},{"key":"161_CR13","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1093\/eurpub\/cki168","volume":"16","author":"AM Bargagli","year":"2006","unstructured":"Bargagli, A. M. et al. Drug-related mortality and its impact on adult mortality in eight European countries. Eur. J. Public Health 16, 198\u2013202 (2006).","journal-title":"Eur. J. Public Health"},{"key":"161_CR14","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3399\/bjgp16X685333","volume":"66","author":"C Cornford","year":"2016","unstructured":"Cornford, C. & Close, H. The physical health of people who inject drugs: complexities, challenges, and continuity. Br. J. Gen. Pract. 66, 286\u2013287 (2016).","journal-title":"Br. J. Gen. Pract."},{"key":"161_CR15","doi-asserted-by":"crossref","first-page":"377","DOI":"10.4104\/pcrj.2012.00069","volume":"21","author":"F Palmer","year":"2012","unstructured":"Palmer, F. et al. Prevalence of common chronic respiratory diseases in drug misusers: a cohort study. Prim. Care Respir. J. 21, 377\u2013383 (2012).","journal-title":"Prim. Care Respir. J."},{"key":"161_CR16","first-page":"PA4178","volume":"48","author":"J Furlong","year":"2016","unstructured":"Furlong, J. et al. Prevalence of COPD in heroin smokers screened at substance misuse clinics. Eur. Respir. J. 48, PA4178 (2016).","journal-title":"Eur. Respir. J."},{"key":"161_CR17","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1378\/chest.15-0236","volume":"148","author":"PP Walker","year":"2015","unstructured":"Walker, P. P., Thwaite, E., Amin, S., Curtis, J. M. & Calverley, P. M. A. The association between heroin inhalation and early onset emphysema. Chest 148, 1156\u20131163 (2015).","journal-title":"Chest"},{"key":"161_CR18","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.chest.2018.08.1049","volume":"155","author":"H Burhan","year":"2019","unstructured":"Burhan, H. et al. Screening heroin smokers attending community drug services for COPD. Chest 155, 279\u2013287 (2019).","journal-title":"Chest"},{"key":"161_CR19","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1176\/ps.2009.60.1.43","volume":"60","author":"JD Baxter","year":"2009","unstructured":"Baxter, J. D., Samnaliev, M. & Clark, R. E. The quality of asthma care among adults with substance-related disorders and adults with mental illness. Psychiatr. Serv. 60, 43\u201349 (2009).","journal-title":"Psychiatr. Serv."},{"key":"161_CR20","unstructured":"Royal College of Physicians. The National Review of asthma deaths: why asthma still kills. https:\/\/www.rcplondon.ac.uk\/projects\/outputs\/why-asthma-still-kills (London, 2014)."},{"key":"161_CR21","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1080\/10550887.2013.795469","volume":"32","author":"P Caponnetto","year":"2013","unstructured":"Caponnetto, P. et al. \u201cDangerous relationships\u201d: asthma and substance abuse. J. Addict. Dis. 32, 158\u2013167 (2013).","journal-title":"J. Addict. Dis."},{"key":"161_CR22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0140995","volume":"10","author":"CJ Jolley","year":"2015","unstructured":"Jolley, C. J., Bell, J., Rafferty, G. F., Moxham, J. & Strang, J. Understanding heroin overdose: a study of the acute respiratory depressant effects of injected pharmaceutical heroin. PLoS ONE 10, e0140995 (2015).","journal-title":"PLoS ONE"},{"key":"161_CR23","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0147-9563(98)90049-8","volume":"27","author":"R Cruz","year":"1998","unstructured":"Cruz, R. et al. Pulmonary manifestations of inhaled street drugs. Heart Lung 27, 297\u2013305 (1998).","journal-title":"Heart Lung"},{"key":"161_CR24","first-page":"j3750","volume":"355","author":"J Middleton","year":"2016","unstructured":"Middleton, J., McGrail, S. & Stringer, K. Drug related deaths in England and Wales. BMJ 355, j3750 (2016).","journal-title":"BMJ"},{"key":"161_CR25","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s11606-009-1225-0","volume":"25","author":"V Modesto-Lowe","year":"2010","unstructured":"Modesto-Lowe, V., Brooks, D. & Petry, N. Methadone deaths: risk factors in pain and addicted populations. J. Gen. Intern. Med. 25, 305\u2013309 (2010).","journal-title":"J. Gen. Intern. Med."},{"key":"161_CR26","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/add.13099","volume":"111","author":"J Guydish","year":"2016","unstructured":"Guydish, J. et al. An international systematic review of smoking prevalence in addiction treatment. Addiction 111, 220\u2013230 (2016).","journal-title":"Addiction"},{"key":"161_CR27","doi-asserted-by":"crossref","DOI":"10.1038\/s41533-017-0052-8","volume":"27","author":"A Gilkes","year":"2017","unstructured":"Gilkes, A. et al. Ethnic differences in smoking intensity and COPD risk: an observational study in primary care. NPJ Prim. Care Respir. Med. 27, 50 (2017).","journal-title":"NPJ Prim. Care Respir. Med."},{"key":"161_CR28","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1046\/j.1360-0443.2000.951116697.x","volume":"95","author":"DR Taylor","year":"2000","unstructured":"Taylor, D. R., Poulton, R., Moffitt, T. E., Ramankutty, P. & Sears, M. R. The respiratory effects of cannabis dependence in young adults. Addiction 95, 1669\u20131677 (2000).","journal-title":"Addiction"},{"key":"161_CR29","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1183\/09031936.00065009","volume":"35","author":"RJ Hancox","year":"2010","unstructured":"Hancox, R. J. et al. Effects of cannabis on lung function: a population-based cohort study. Eur. Respir. J. 35, 42\u201347 (2010).","journal-title":"Eur. Respir. J."},{"key":"161_CR30","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1007\/s11524-012-9780-9","volume":"90","author":"P Leece","year":"2013","unstructured":"Leece, P., Rajaram, N., Woolhouse, S. & Millson, M. Acute and chronic respiratory symptoms among primary care patients who smoke crack cocaine. J. Urban Health 90, 542\u2013551 (2013).","journal-title":"J. Urban Health"},{"key":"161_CR31","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1378\/chest.121.4.1223","volume":"121","author":"A Boto de los Bueis","year":"2002","unstructured":"Boto de los Bueis, A. et al. Bronchial hyperreactivity in patients who inhale heroin mixed with cocaine vaporized on aluminum foil. Chest 121, 1223\u20131230 (2002).","journal-title":"Chest"},{"key":"161_CR32","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1378\/chest.123.2.510","volume":"123","author":"AJ Krantz","year":"2003","unstructured":"Krantz, A. J. et al. Heroin insufflation as a trigger for patients with life-threatening asthma*. Chest 123, 510\u2013517 (2003).","journal-title":"Chest"},{"key":"161_CR33","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1016\/S0012-3692(15)52588-9","volume":"128","author":"M Levine","year":"2005","unstructured":"Levine, M., Iliescu, M. E., Margellos-Anast, H., Estarziau, M. & Ansell, D. A. The effects of cocaine and heroin use on intubation rates and hospital utilization in patients with acute asthma exacerbations. Chest 128, 1951\u20131957 (2005).","journal-title":"Chest"},{"key":"161_CR34","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1378\/chest.107.1.233","volume":"107","author":"DY Haim","year":"1995","unstructured":"Haim, D. Y., Lippmann, M. L., Goldberg, S. K. & Walkenstein, M. D. The pulmonary complications of crack cocaine: a comprehensive review. Chest 107, 233\u2013240 (1995).","journal-title":"Chest"},{"key":"161_CR35","unstructured":"NHS Digital. Quality & Outcomes Framework (QOF) 2016-2017. https:\/\/digital.nhs.uk\/data-and-information\/publications\/statistical\/quality-and-outcomes-framework-achievement-prevalence-and-exceptions-data\/quality-and-outcomes-framework-qof-2016-17 (2017)."},{"key":"161_CR36","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1093\/pubmed\/fdq031","volume":"33","author":"L Nacul","year":"2011","unstructured":"Nacul, L. et al. COPD in England: a comparison of expected, model-based prevalence and observed prevalence from general practice data. J. Public Health 33, 108\u2013116 (2011).","journal-title":"J. Public Health"},{"key":"161_CR37","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1136\/thx.2006.067785","volume":"61","author":"DM Mannino","year":"2006","unstructured":"Mannino, D. M. Underdiagnosed chronic obstructive pulmonary disease in England: new country, same story. Thorax 61, 1032 (2006).","journal-title":"Thorax"},{"key":"161_CR38","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1001\/archinte.167.3.221","volume":"167","author":"JM Tetrault","year":"2007","unstructured":"Tetrault, J. M. et al. Effects of marijuana smoking on pulmonary function and respiratory complications: a systematic review. Arch. Intern. Med. 167, 221\u2013228 (2007).","journal-title":"Arch. Intern. Med."},{"key":"161_CR39","first-page":"473","volume":"53","author":"AJ Riley","year":"2003","unstructured":"Riley, A. J., Harding, G., Underwood, M. R. & Carter, Y. H. Homelessness: a problem for primary care? Br. J. Gen. Pract. 53, 473 (2003).","journal-title":"Br. J. Gen. Pract."},{"key":"161_CR40","volume":"16","author":"LE Ross","year":"2015","unstructured":"Ross, L. E. et al. Barriers and facilitators to primary care for people with mental health and\/or substance use issues: a qualitative study. BMC Fam. Pract. 16, 135 (2015).","journal-title":"BMC Fam. Pract."},{"key":"161_CR41","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2011-000153","volume":"1","author":"RE Jordan","year":"2011","unstructured":"Jordan, R. E., Cheng, K. K., Miller, M. R. & Adab, P. Passive smoking and chronic obstructive pulmonary disease: cross-sectional analysis of data from the Health Survey for England. BMJ Open 1, e000153 (2011).","journal-title":"BMJ Open"},{"key":"161_CR42","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1089\/jpm.2015.0525","volume":"19","author":"F Courtemanche","year":"2016","unstructured":"Courtemanche, F., Dao, D., Gagne, F., Tremblay, L. & Neron, A. Methadone as a coanalgesic for palliative care cancer patients. J. Palliat. Med. 19, 972\u2013978 (2016).","journal-title":"J. Palliat. Med."},{"key":"161_CR43","doi-asserted-by":"crossref","first-page":"A201","DOI":"10.1136\/thoraxjnl-2016-209333.357","volume":"71","author":"CJ Jolley","year":"2016","unstructured":"Jolley, C. J. et al. P214 The prevalence of respiratory symptoms and lung disease in a south london \u201clung health in addictions\u201d service. Thorax 71, A201 (2016).","journal-title":"Thorax"},{"key":"161_CR44","first-page":"285","volume":"22","author":"AM Tatum","year":"2001","unstructured":"Tatum, A. M., Greenberger, P. A., Mileusnic, D., Donoghue, E. R. & Lifschultz, B. D. Clinical, pathologic, and toxicologic findings in asthma deaths in Cook County, Illinois. Allergy Asthma Proc. 22, 285\u2013291 (2001).","journal-title":"Allergy Asthma Proc."},{"key":"161_CR45","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1378\/chest.110.3.604","volume":"110","author":"T Levenson","year":"1996","unstructured":"Levenson, T., Greenberger, P. A., Donoghue, E. R. & Lifschultz, B. D. Asthma deaths confounded by substance abuse: an assessment of fatal asthma. Chest 110, 604\u2013610 (1996).","journal-title":"Chest"},{"key":"161_CR46","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1111\/j.1360-0443.2008.02351.x","volume":"103","author":"B Boland","year":"2008","unstructured":"Boland, B. et al. Salbutamol inhaler misuse: a persisting problem? Addiction 103, 1907\u20131907 (2008).","journal-title":"Addiction"},{"key":"161_CR47","unstructured":"Strang, J., Drummond, C., McNeil, A., Lader, M. & Marsden, J. In Annual Report of the Chief Medical Officer 2013, Public Mental Health Priorities: Investing in the Evidence. (eds Mehta, N. & Murphy, O.) Ch. 16 (Department of Health, London, 2013)."},{"key":"161_CR48","unstructured":"Cancer Research UK. Don\u2019t quit on us. A campaign to take action on tobacco. http:\/\/www.cancerresearchuk.org\/support-us\/campaign-for-us\/dont-quit-on-us-0 (2017)."},{"key":"161_CR49","unstructured":"Action on Smoking and Health and Cancer Research UK. Cutting down: the reality of budget cuts to local tobacco control. https:\/\/www.cancerresearchuk.org\/sites\/default\/files\/local_authority_survey_2016_report_cruk_finalfinal.pdf (2016)."},{"key":"161_CR50","unstructured":"Independent Expert Working Group. Drug Misuse and Dependence. UK Guidelines On Clinical Management (Department of Health, London, 2017)."},{"key":"161_CR51","volume":"6","author":"CA Mitchell","year":"2016","unstructured":"Mitchell, C. A. et al. Respiratory health screening for opiate misusers in a specialist community clinic: a mixed-methods pilot study, with integrated staff and service user feedback. BMJ Open 6, e012823 (2016).","journal-title":"BMJ Open"},{"key":"161_CR52","doi-asserted-by":"crossref","DOI":"10.1186\/1472-6963-14-304","volume":"14","author":"C Cookson","year":"2014","unstructured":"Cookson, C. et al. Smoking and its treatment in addiction services: clients\u2019 and staff behaviour and attitudes. BMC Health Serv. Res. 14, 304 (2014).","journal-title":"BMC Health Serv. Res."},{"key":"161_CR53","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/hup.630","volume":"19","author":"JM Corkery","year":"2004","unstructured":"Corkery, J. M., Schifano, F., Ghodse, A. H. & Oyefeso, A. The effects of methadone and its role in fatalities. Hum. Psychopharmacol. 19, 565\u2013576 (2004).","journal-title":"Hum. Psychopharmacol."},{"key":"161_CR54","unstructured":"Department for Communities and Local Government. The English indices of multiple deprivation. https:\/\/www.gov.uk\/government\/statistics\/english-indices-of-deprivation-2015 (2015)."},{"key":"161_CR55","unstructured":"NHS Digital. Quality and outcomes framework QOF business rules v36.0. https:\/\/digital.nhs.uk\/data-and-information\/data-collections-and-data-sets\/data-collections\/quality-and-outcomes-framework-qof\/quality-and-outcome-framework-qof-business-rules\/quality-and-outcomes-framework-qof-business-rules-v36-0 (2016)."}],"container-title":["npj Primary Care Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41533-019-0161-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41533-019-0161-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41533-019-0161-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T03:09:13Z","timestamp":1722308953000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41533-019-0161-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,14]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["161"],"URL":"https:\/\/doi.org\/10.1038\/s41533-019-0161-7","relation":{},"ISSN":["2055-1010"],"issn-type":[{"type":"electronic","value":"2055-1010"}],"subject":[],"published":{"date-parts":[[2020,1,14]]},"assertion":[{"value":"24 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Kelleher M. has received funding from Abbievie, Gilead, Indivior, Reckitt Benckiser, Camerus, and Braeburn pharma. The other authors report no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4"}}